The Amplia and Compia MRI Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan devices were the first CRT-D devices that were approved by the FDA as MRI compatible. These devices can cost upwards of 10 lakh.
CRT devices were previously not compatible with MRI scans due to a possible interaction between the devices.
The device is an implantable Cardiac Resynchronization Therapy defibrillator for heart failure patients that is meant to stop life-threatening ventricular tachycardia and fibrillation with relatively weak electrical shocks. CRT-Ds better a diseased hearts’ effectiveness and increases blood flow. They improve heart failure symptoms like fatigue, shortness of breath and exercise intolerance, and significantly lowers the risk of life-threatening cardiac events. Many patients’ quality of life improves considerably with a CRT-D.
However, surgery is necessary to implant the device. The implantation procedure will cost you around USD 15,959 in India. Overall, the one-year and 5-year survival rates after implantation is 88 per cent and 54 per cent.
Older CRT devices’ longevity at five years was 54%. However, recent-generation CRT-Ds displayed better durability.
